01453nas a2200157   4500000000100000008004100001260003500042100001800077700001600095245007500111856007100186300001000257490000600267520099700273022002501270       2021                            d  bShanlax International Journals1 aSangamithra A1 aDhavamani P00aMorbidity Management and Disability Prevention of Lymphatic Filariasis  uhttps://ideas.repec.org/a/acg/journl/v9y2021i3p24-28.html#download  a24-280 v93 a<jats:p>Lymphatic Filariasis (LF) vector-borne, chronically disabling parasitic contamination inflicting elephantiasis, lymphoedema, and hydrocele, is a leading public strength convenience as nicely as serious socioeconomic trouble due to its morbid condition, social stigma, and massive financial loss in many creating nations, and this sickness has been ranked as the second primary purpose of long-term continual incapacity worldwide. World Health Assembly decision in 1997 for Eliminate of Lymphatic Filariasis (ELF) via 2020 made all the filaria endemic nations in the world put efforts for its removing with the aid of regularly decreasing and finally interrupting the transmission of Lymphatic Filariasis (LF). Another lookup is wished to aid efforts to ‘scale-up morbidity manipulation and incapacity alleviation programs at the countrywide stage and to report the extent to which anti-filarial drug cure influences the direction of filariasis associated disorder.</jats:p>  a2582-0192, 2319-961X